1. Stovner LJ, Nichols E, Steiner TJ, et al. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954-976. doi:10.1016/s1474-4422(18)30322-3
2. Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: Updated age, sex, and socioeconomic-specific estimates from government health surveys. Headache. 2021;61(1):60-68. doi:10.1111/head.14024
3. Merikangas KR, Risch NJ, Merikangas JR, Weissman MM, Kidd KK. Migraine and depression: Association and familial transmission. J Psychiatr Res. 1988;22(2):119-129. doi:10.1016/0022-3956(88)90076-3
4. Kelman L. The Triggers or Precipitants of the Acute Migraine Attack. Cephalalgia. 2007;27(5):394-402. doi:10.1111/j.1468-2982.2007.01303.x
5. Blumenfeld A, Ashkenazi A, Napchan U, et al. Expert Consensus Recommendations for the Performance of Peripheral Nerve Blocks for Headaches- A Narrative Review. Headache: The Journal of Head and Face Pain. 2013;53(3):437-446. doi:10.1111/head.12053
6. Ashkenazi A, Matro R, Shaw JW, Abbas MA, Silberstein SD. Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: a randomised comparative study. J Neurol Neurosurg Psychiatry. 2008;79(4):415-417. doi:10.1136/jnnp.2007.124420
7. Levin M. Nerve blocks in the treatment of headache. Neurotherapeutics. 2010;7(2):197-203. doi:10.1016/j.nurt.2010.03.001
8. Allen SM, Mookadam F, Cha SS, Freeman JA, Starling AJ, Mookadam M. Greater Occipital Nerve Block for Acute Treatment of Migraine Headache: A Large Retrospective Cohort Study. J Am Board Fam Med. 2018;31(2):211-218. doi:10.3122/jabfm.2018.02.170188
9. Chowdhury D, Datta D, Mundra A. Role of Greater Occipital Nerve Block in Headache Disorders: A Narrative Review. Neurol India. 2021;69(7):228-256. doi:10.4103/0028-3886.315993
10. Matute E, Bonilla S, Gironés A, Planas A. Bilateral greater occipital nerve block for post-dural puncture headache. Anaesthesia. 2008;63(5):557-558. doi:10.1111/j.1365-2044.2008.05531.x
11. Weatherall M. Idiopathic Trigeminal Neuropathy May Respond to Greater Occipital Nerve Injection. Cephalalgia. 2008;28(6):664-666. doi:10.1111/j.1468-2982.2008.01561.x
12. Rozen T. Cessation of Hemiplegic Migraine Auras With Greater Occipital Nerve Blockade. Headache: The Journal of Head and Face Pain. 2007;47(6):917-919. doi:10.1111/j.1526-4610.2007.00828.x
13. Hecht JS. Occipital Nerve Blocks in Postconcussive Headaches. Journal of Head Trauma Rehabilitation. 2004;19(1):58-71. doi:10.1097/00001199-200401000-00006
14. Peres M, Stiles M, Siow H, Rozen T, Young W, Silberstein S. Greater Occipital Nerve Blockade for Cluster Headache. Cephalalgia. 2002;22(7):520-522. doi:10.1046/j.1468-2982.2002.00410.x
15. Bovim G, Sand T. Cervicogenic headache, migraine without aura and tension-type headache. Diagnostic blockade of greater occipital and supra-orbital nerves. Pain. 1992;51(1):43-48. doi:10.1016/0304-3959(92)90007-x
16. Rothbart P, Fiedler K, Gale GD, Nussbaum D, Hendlerb N. A Descriptive Study of 100 Patients Undergoing Palliative Nerve Blocks for Chronic Intractable Headache and Neck Ache. Pain Res Manag. 2000;5(4):243-248. doi:10.1155/2000/706434
17. Leinisch-Dahlke E, Jirgens T, Bogdahn U, Jakob W, May A. Greater Occipital Nerve Block is Ineffective in Chronic Tension Type Headache. Cephalalgia. 2005;25(9):704-708. doi:10.1111/j.1468-2982.2004.00941.x
18. Tobin JA, Flitman SS. Occipital Nerve Blocks: Effect of Symptomatic Medication. Headache. 2009;49(10):1479-1485. doi:10.1111/j.1526-4610.2009.01549.x
19. Do TP, Remmers A, Schytz HW, et al. Red and orange flags for secondary headaches in clinical practice. Neurology. 2019;92(3):134-144. doi:10.1212/wnl.0000000000006697
20. Olesen J. Headache Classification Committee of the International Headache Society(IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1-211.
21. Lipton RB, Baggish JS, Stewart WF, Codispoti JR, Fu M. Efficacy and Safety of Acetaminophen in the Treatment of Migraine Results of a Randomized, Double-blind, Placebo-Controlled, Population-Based Study.
22. Diener HC, Gaul C, Lehmacher W, Weiser T. Aspirin, paracetamol(acetaminophen) and caffeine for the treatment of acute migraine attacks: A systemic review and meta-analysis of randomized placebo-controlled trials. Euro J Neurology. 2021;29(1):350-357. doi:10.1111/ene.15103
23. Cameron C, Kelly S, Hsieh SC, et al. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis. Headache. 2015;55:221-235. doi:10.1111/head.12601
24. Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78(17):1337-1345. doi:10.1212/wnl.0 b013e3182535d20
25. Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78(17):1337-1345. doi:10.1212/wnl.0 b013e3182535d20
26. Coppola G, Di Lorenzo C, Serrao M, Parisi V, Schoenen J, Pierelli F. Pathophysiological targets for non-pharmacological treatment of migraine. Cephalalgia. 2016;36(12):1103-1111. doi:10.1177/0333102415620908
27. Seo BF, Jung SN, Sohn WI, Kwon H. Lymph node compression of the lesser occipital nerve: a cause of migraine. J Plast Reconstr Aesthet Surg. 2011;64(12):1657-1660. doi:10.1016/j.bjps.2011.04.007
28. Intracellular calcium during excitation-contraction coupling in mammalian ventricle-PubMed. https://pubmed.ncbi.nlm.nih.gov/1661830/
29. Schueler M, Neuhuber WL, De Col R, Messlinger K. Innervation of rat and human dura mater and pericranial tissues in the parieto-temporal region by meningeal afferents. Headache. 2014;54(6):996-1009. doi:10.1111/head.12371
30. Schueler M, Messlinger K, Dux M, Neuhuber WL, de Col R. Extracranial projections of meningeal afferents and their impact on meningeal nociception and headache. Pain. 2013;154(9):1622-1631. doi:10.1016/j.pain.2013.04.040
31. Lous I, Olesen J. Evaluation of pericranial tenderness and oral function in patients with common migraine, muscle contraction headache and ‘combination headache.' Pain. 1982;12(4):385-393. doi:10.1016/0304-3959(82)90183-x
32. Ambrosini A, D'Alessio C, Magis D, Schoenen J. Targeting pericranial nerve branches to treat migraine: Current approaches and perspectives. Cephalalgia. 2015;35(14):1308-1322. doi:10.1177/0333102415573511
33. Ambrosini A, Schoenen J. Invasive pericranial nerve interventions. Cephalalgia. 2016;36(12):1156-1169. doi:10.1177/0333102416639515
34. Lambru G, Lagrata S, Matharu MS. Cutaneous atrophy and alopecia after greater occipital nerve injection using triamcinolone. Headache. 2012;52(10):1596-1599. doi:10.1111/j.1526-4610.2012.02270.x
35. Fernandes L, Randall M, Idrovo L. Peripheral nerve blocks for headache disorders. Pract Neurol. 2020;21:30-35. doi:10.1136/practneurol-2020-002612
36. Kerr FWL. A mechanism to account for frontal headache in cases of posterior-fossa tumors. J Neurosurg. 1961;18(5):605-609. doi:10.3171/jns.1961.18.5.0605
37. Kwon HJ, Kim HS, O J, et al. Anatomical analysis of the distribution patterns of occipital cutaneous nerves and the clinical implications for pain management. J Pain Res. 2018;11:2023-2031. doi:10.2147/ipr.s175506
38. Bovim G, Sand T. Cervicogenic headache, migraine without aura and tension-type headache. Diagnostic blockade of greater occipital and supra-orbital nerves. Pain. 1992;51(1):43-48. doi:10.1016/0304-3959(92)90007-x
39. Ashkenazi A, Young WB. The effects of greater occipital nerve block and trigger point injection on brush allodynia and pain in migraine. Headache. 2005;45(4):350-354. doi:10.1111/j.1526-4610.2005.05073.x
40. Inan LE, Inan N, Karadas O, et al. Greater occipital nerve blockade for the treatment of chronic migraine: a randomized, multicenter, double-blind, and placebo-controlled study. Acta Neurol Scand. 2015;132(4):270-277. doi:10.1111/ane.12393
41. Ultrasound-guided greater occipital nerve block: an efficient technique in chronic refractory migraine without aura? PubMed. https://pubmed.ncbi.nlm.nih.gov/25794201/
42. Kashipazha D, Nakhostin-Mortazavi A, Mohammadianinejad SE, Bahadoram M, Zandifar S, Tarahomi S. Preventive effect of greater occipital nerve block on severity and frequency of migraine headache. Glob J Health Sci. 2014;6(6):209-213. doi:10.5539/gjhs.v6n6p209
43. Ilhan Alp S, Alp R. Supraorbital and infraorbital nerve blockade in migraine patients: results of 6-month clinical follow-up. Eur Rev Med Pharmacol Sci. 2013;17:1778-1781.
44. Caputi CA, Firetto V. Therapeutic Blockade of Greater Occipital and Supraorbital Nerves in Migraine Patients. Headache. 1997;37(3):174-179. doi:10.1046/j.1526-4610.1997.3703174.x
45. Demirsoy M, Erdil A, Tu"mer M. Evaluation of the Efficacy of Auriculotemporal Nerve Block in Temporomandibular Disorders. J Oral Facial Pain Headache. 2021;35:326-331. doi:10.11607/ofph.2949
46. Morgan A, Romanello G. Use of the Sphenopalatine Ganglion Block to Treat Migraine Headaches in the Emergency Department. Cureus. 2022;14.
47. Binfalah M, Alghawi E, Shosha E, Alhilly A, Bakhiet M. Sphenopalatine Ganglion Block for the Treatment of Acute Migraine Headache. Pain Res Treat. 2018;2018:1-6. doi:10.1155/2018/2516953
48. Candido KD, Massey ST, Sauer R, Darabad RR, Knezevic NN. A novel revision to the classical transnasal topical sphenopalatine ganglion block for the treatment of headache and facial pain. Pain Phys. 2013;6;16(6;11):E769-E778. doi:10.36076/ppj.2013/16/e769
49. Persson LCG, Carlsson JY, Anderberg L. Headache in patients with cervical radiculopathy: a prospective study with selective nerve root blocks in 275 patients. Eur Spine J. 2007;16(7):953-959. doi:10.1007/s00586-006-0268-8
50. Lord SM, Barnsley L, Wallis BJ, Bogduk N. Third occipital nerve headache: a prevalence study. J Neurol Neurosurg Psychiatry. 1994;57(10):1187-1190. doi:10.1136/jnnp.57.10.1187
51. Desantana JM, da Silva LFS, de Resende MA, Sluka KA. Transcutaneous electrical nerve stimulation at both high and low frequencies activates ventrolateral periaqueductal grey to decrease mechanical hyperalgesia in arthritic rats. Neuroscience. 2009;163(4):1233-1241. doi:10.1016/j.neuroscience.2009.06.056
52. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150(3699):971-979. doi:10.1126/science.150.3699.971
53. Cruccu G, Aziz TZ, Garcia-Larrea L, et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol. 2007;14(9):952-970. doi:10.1111/j.1468-1331.2007.01916.x
54. Weiner RL, Reed KL. Peripheral neurostimulation for control of intractable occipital neuralgia. Neuromodulation. 1999;2(3):217-221. doi:10.1046/j.1525-1403.1999.00217.x
55. Magis D, Schoenen J. Advances and challenges in neurostimulation for headaches. Lancet Neurol. 2012;11(8):708-719. doi:10.1016/s1474-4422(12)70139-4
56. Magis D, Sava S, d'Elia TS, Baschi R, Schoenen J. Safety and patients' satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population. J Headache Pain. 2013;14(1):95. doi:10.1186/1129-2377-14-95
57. Schoenen J, Vandersmissen B, Jeangette S, et al. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013;80(8):697-704. doi:10.1212/wn 1.0b013e3182825055
58. Goadsby PJ, Grosberg BM, Mauskop A, Cady R, Simmons KA. Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study. Cephalalgia. 2014;34(12):986-993. doi:10.1177/0333102414524494
59. Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011;31(3):271-285. doi:10.1177/0333102410381142
60. Silberstein SD, Dodick DW, Saper J, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2012;32(16):1165-1179. doi:10.1177/0333102412462642
 61. Lenaerts ME, Oommen KJ, Couch JR, Skaggs V. Can vagus nerve stimulation help migraine? Cephalalgia. 2008;28(4):392-395. doi:10.1111/j.1468-2982.2008.01538.x
 62. Ruiz Pinero M, et al. Pericranial nerve blockade as a preventive treatment for migraine: Experience in 60 patients. Neurologia. 2016;31:445-451.